SEC Form 4 · accession 0001209191-18-003903
HCI Group, Inc. · HCI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anthony Saravanos
Officer — Division President · Director
Period of report
Jan 15, 2018
Accepted (ET)
Jan 17, 2018 · 3:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001400810
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF3 | Jan 15, 2018 | F | 205 | $34.52 | D | 0 | D | |
| Common stock | holding | — | — | — | 1,200 | I | By Self as Custodian for niece, Elliana Tuite | |
| Common stock | holding | — | — | — | 1,200 | I | By Self as Custodian for nephew, Nolan Tuite | |
| Common stockF1 | holding | — | — | — | 80,000 | I | By HC Investment LLC | |
| Common stock | holding | — | — | — | 1,200 | I | By Self and Maria Saravanos as Custodian for son, Kostos Anthony Saravanos | |
| Common stockF2 | holding | — | — | — | 18,000 | D | ||
| Common stockF4 | holding | — | — | — | 2,091 | D | ||
| Common Stock | holding | — | — | — | 29,667 | D | ||
| Common StockF5 | holding | — | — | — | 2,324 | D | ||
| Common StockF6 | holding | — | — | — | 2,500 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person holds voting and investment power of the 80,000 shares held by HC Investment LLC.
- F2Restricted stock grant of 24,000 shares effective 05/16/13: The Issuer cancelled effective 3/2/2016 the 6,000 share tranche of this grant that was to have vested one year after the closing price of HCI common shares equaled or exceeded $50 per share for 20 consecutive trading days. Of the award's 18,000 remaining shares, 6,000 have previously vested, 6,000 shares will vest one year after the closing price of HCI common shares equals or exceeds $65 per share for 20 consecutive trading days, and 6,000 will vest one year after the closing price of HCI common shares equals or exceeds $80 per share for 20 consecutive trading days. All shares for which restrictions have not lapsed 6 years and one day from the grant date will be forfeited. These shares were granted by the Company pursuant to the Company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 5/16/2013.
- F3205 shares were surrendered to cover the minimum federal income tax liability associated with the January 15, 2018 vesting of the last tranche of 625 restricted shares of this grant originally awarded February 28, 2014.
- F4Restricted stock grant of 2,500 shares effective 5/20/2015: Restriction period will lapse and the restricted shares will vest as follows: 625 shares on each of May 20, 2016, May 20, 2017, May 20, 2018, and May 20, 2019. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 5/20/2015. The number of shares reported in column 5 includes 1,250 unvested shares pursuant to this 5/20/15 restricted stock grant.
- F5Restricted stock grant of 2,500 shares effective 6/06/2016: Restriction period will lapse and the restricted shares will vest as follows: 625 shares on each of May 20, 2017, May 20, 2018, May 20, 2019, and May 20, 2020. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 6/06/2016. The number of shares reported in column 5 includes 1,875 unvested shares pursuant to this 6/06/16 restricted stock grant.
- F6Restricted stock grant of 2,500 shares effective 6/06/2017: Restriction period will lapse and the restricted shares will vest as follows: 625 shares on each of May 20, 2018, May 20, 2019, May 20, 2020, and May 20, 2021. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 6/06/2017.